If you need more lookups,
subscriptions start at $34 USD/month.
Mark Warne Location
United Kingdom
Mark Warne Work
2022 -now Advisor @
2016 -now Non Executive Director @
2015 -now CEO and Director @
2020 -2020 Non Executive Director @
2016 -2020 Non Executive Director @ Hvivo PLC
2014 -2018 Non Executive Director @
2009 -2018 Director @
2008 -2018 Head of Healthcare and Life Science Partner @
2012 -2018 Director @
2012 -2016 Director @ Azellon
2012 -2015 Director @ Optimal Medicine
2013 -2015 Director @
2010 -2014 Director @ Activiomics
2011 -2012 Director @
2009 -2012 Director @
2011 -2012 Director @ Bristol Innovations
2010 -2011 Business Development @ Capsant
2008 -2011 Director @ Degrasense
2000 -2008 Managing Director @
2005 -2007 Strategic Affairs Manager @
2000 -2007 Various @
Mark Warne Education
Mark Warne Skills
Business Strategy
Mergers & Acquisitions
Molecular Biology
Chemistry
Venture Capital
Start-ups
Due Diligence
Drug Development
Strategy
Pharmaceutical Industry
Drug Discovery
Commercialization
Biotechnology
Private Equity
Business Development
Life Sciences
R&D
Lifesciences
Entrepreneurship
Technology Transfer
Mark Warne Summary
Mark Warne, based in United Kingdom, is currently a Non Executive Director at Ixico plc. Mark Warne brings experience from previous roles at Angelini Ventures, deepmatter, Open Orphan PLC and Hvivo PLC. With a robust skill set that includes Business Strategy, Mergers & Acquisitions, Molecular Biology, Chemistry, Venture Capital and more. Mark Warne has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Mark Warne?
Find contact details for 700 million professionals.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.